ProKidney Corp
ProKidney Corp (PROK) Covered Calls
As of September 25, 2026, PROK has 5 covered call opportunities in the coming three months. Return ranges from 31.3 to 234.4% until expiration. Annualized return ranges from 37.8 to 177.1%. The nearest expiration is April 16, 2027. Maximum potential profit is $375.
Read more
Running PROK covered calls helps you generate consistent income from ProKidney Corp's shares you already own, turning a long stock position into a yield-producing asset. A covered call on ProKidney Corp involves holding the underlying stock and selling a call option against it, collecting premium in exchange for capping upside at the strike price. Use our scanner to find the best PROK covered calls in real time and filter for the strikes, expiries, and premiums that fit your strategy.
A covered call is one of the most widely used options strategies because it pairs limited risk with a clear income profile: if PROK stays below the strike at expiration, you keep the premium and the shares; if it rises above, you deliver the stock at the strike and still pocket the premium. Selling PROK covered calls works best when implied volatility is elevated, since richer premiums improve the risk-reward. Key inputs to evaluate include strike selection relative to delta, days to expiration, annualized return, and the probability of assignment — all of which determine whether a given ProKidney Corp covered call is worth writing.
ProKidney Corp., a clinical-stage biotechnology, engages in developing cellular therapy candidates. It is developing Renal Autologous Cell Therapy, an autologous homologous cell admixture that is in a Phase III development program, as well as Phase II clinical trials for the treatment of moderate to severe diabetic kidney disease; and Phase I clinical trial for patients with congenital anomalies of the kidney and urinary tract. The company was founded in 2015 and is headquartered in Winston-Salem, North Carolina.
Income-focused investors, long-term PROK holders, and systematic premium sellers all face the same challenge: finding the covered call strike and expiry that balances yield against the risk of being called away. Our scanner ranks covered calls by annualized return, downside protection, and probability of profit, so selling PROK covered calls becomes a measured decision instead of a guess. Stop eyeballing the chain — let the best ProKidney Corp covered calls come to you, already filtered for the metrics that matter.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile58.73% Neutral
- Market cap (M$)484
- 52 weeks high-54.02%
- 52 weeks low23.08%
- Analyst recommendationBuy
2.00 - Target price$6.25
290.63% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-09
- P/E—
- Future P/E—
- EPS (ttm)-0.55
- EPS growth next 5 years9.79%
As of September 25, 2026
| 2028-01-21 | 483 | 5.00 | 212.50 | 0.35 | 0.75 | 375.00 | 234.38 | 177.12 | -21.88 | +0.55 | 43 | 0.40 |
| 2028-01-21 | 483 | 4.00 | 150.00 | 0.10 | 0.90 | 250.00 | 156.25 | 118.08 | -6.25 | +0.54 | 2,517 | 0.80 |
| 2028-01-21 | 483 | 3.00 | 87.50 | 0.30 | 1.30 | 170.00 | 106.25 | 80.29 | -18.75 | +0.70 | 353 | 1.00 |
| 2027-04-16 | 203 | 2.00 | 25.00 | 0.10 | 1.10 | 50.00 | 31.25 | 56.19 | -6.25 | +0.65 | 15 | 1.00 |
| 2028-01-21 | 483 | 2.00 | 25.00 | 0.40 | 1.40 | 80.00 | 50.00 | 37.78 | -25.00 | +0.77 | 22 | 1.00 |
As of September 25, 2026
Sell covered calls with the data behind you
Find the best PROK covered call setups ranked by annualized return, filter by premium, delta, and days to expiration, and act on the opportunity in seconds.
Start your 14-day free trial→